along with biochemical and clinical features of metabolic syndrome which were found to persist even after successful cure of hypercortisolism [7, 8] . Based on all these evidence, it has been postulated that, the existence of metabolic syndrome in the form of abdominal obesity and decreased insulin sensitivity during the active phase of CS and its persistence even after therapeutic normalization of cortisol levels, probably induce a state of endothelial dysfunction leading to premature atherosclerosis and consequent morbidity and mortality in these patients [3, 7, 8] .
High plasma cortisol levels have been linked to the presence and severity of coronary atherosclerosis in patients who presented with clinical and electrocardiographic evidence of coronary artery disease [9] . Recently, a direct causative role of cortisol in the induction of vascular endothelial dysfunction has been suggested by studies conducted in patients treated with exogenous glucocorticoids [10] and normal human subjects administered with short term oral hydrocortisone All India Institute of Medical Sciences, New Delhi. A written informed consent was obtained from all the subjects before enrolment.
Consecutive cases of endogenous Cushing's syndrome admitted in the endocrine ward of All India Institute of Medical Sciences were included in the study. In patients with clinically apparent Cushing's syndrome, diagnosis of endogenous hypercortisolism was confirmed by low dose dexamethasone suppression test (LDDST). Patients were given 0.5mg of dexamethasone six hourly for 48 hrs starting at 8:00am on day 1 and plasma cortisol was measured at 8:00am after 48hrs. A plasma cortisol value of more than or equal to 2 µg/dL was considered confirmatory for endogenous hypercortisolism. Patients diagnosed with coexisting diabetes mellitus based on fasting plasma glucose levels ≥ 126 mg/dL as per American Diabetes Association criteria were excluded from the study to avoid the potential confounding effect of diabetes on vascular functions. Exclusion criteria also included other disease conditions which can independently affect vascular functions including coronary artery disease, congestive heart failure and chronic kidney disease based on clinical and biochemical criteria. Patients who were under antihypertensive medications (Calcium channel blockers, Beta blockers) were asked to continue the same during the course of assessment of vascular functions. Controls included age (± 5years) and gender matched non-overweight (BMI<25 as per WHO criteria), nonsmoking healthy volunteers who were reported to be free from any acute or chronic illness and not under any kind of medications. Measurement of morning (8:30 am to 9:30 am) fasting serum cortisol levels were done in all recruited patients and controls on the day of vascular function assessment.
Assessment of vascular function
Vascular reactivity and endothelial function were assessed by measuring the pulse wave form and pulse transit time responses during reactive hyperemia using simultaneously acquired lead II ECG and finger PPG signals. MP150 (BIOPAC Systems Inc., CA, USA), a computer based digital data acquisition system with Ethernet interfacing and software Acqknowledge® 3.8.2 was employed to record ECG and PPG signals at a sampling rate of 1kHz. PPG acquisition unit essentially comprised of an infrared (860±6 nm), reflection type photoelectric transducer (TSD200) and a biopotential amplifier (PPG100C) with a preset of gain and acetate [11] , based on forearm blood flow responses to reactive hyperemia and intra-arterially infused acetylcholine respectively. In both these studies patients and subjects were shown to be free of any of the clinical or biochemical features of glucocorticoid induced metabolic syndrome suggesting that excess glucocorticoid levels can per se affect vascular endothelial function. Pathological changes in vascular structure and function in patients with excess circulating glucocorticoid levels due to an endogenous or exogenous cause have also been linked to an increased oxidative stress in them [10, 12] .
Even though literature review suggests a high likelihood of derangements in vascular reactivity and endothelial function in CS associated endogenous hypercortisolism, only very few studies have directly addressed this question by in vivo assessment of vascular functions [13] [14] [15] . We hypothesized that vascular reactivity and endothelial function would be deranged in CS and these pathophysiological changes would be related to the levels of hypercortisolism and/or oxidative stress in these patients.
Multiple studies in the past have shown monitoring of peripheral pulse wave form changes during reactive hyperemia as a well validated technique to assess vascular reactivity and endothelial function [16] [17] [18] . Photoplethysmography (PPG) is an optical measurement technique used to record digital volume pulse by measuring the pulsatile changes in blood volume in the finger microvasculature using light of infrared wavelength [19, 20, 21] . Photoplethysmographic measurement of peripheral pulse waveform changes is a highly objective and operator independent technique used to assess changes in both the calibre and tone of blood vessels during reactive hyperemia [17, 22] . In this study we assessed and compared the vascular reactivity and endothelial function in patients of CS with those of healthy human subjects by studying the peripheral pulse wave form and pulse transit time (PTT) responses during reactive hyperemia using R wave gated photoplethysmography.
Materials and Methods

Subjects
The study was conducted in 18 patients of endogenous hypercortisolism and 15 age and gender matched healthy controls. The study protocol was approved by Ethics committee for research on human subjects, display. Cuff pressure was released completely after 5 minutes of arterial occlusion and recording was continued during the phase of reactive hyperemia.
All signals recorded and saved in the Acqknowledge ® format were analysed offline using LabChart Pro 7 ® software for the extraction and calculation of the following parameters ( Fig. 1 . All recordings were done in controlled ambient temperature and luminance. Patients and control subjects were asked to report in the vascular function lab after overnight fasting at 8:30 am in the morning. Patients who were smokers were asked to abstain from smoking 24 hrs prior to the recording. Subjects were given 15 minutes of supine rest after which baseline blood pressure was taken. Sphygmomanometer cuff was kept fastened to the arm for subsequent use when arterial occlusion had to be produced. Disposable Ag-AgCl electrodes were placed for recording standard bipolar limb lead II ECG. Photoplethysmograph probe was fixed to the right middle finger with the help of an attached Velcro strap. The entire recording period comprised of 5 minutes of baseline, 5 minutes of arterial occlusion and 5 minutes post release of occlusion during the phase of reactive hyperemia. After 5 minutes of baseline recording of ECG and PPG signals, arterial occlusion was produced in the right arm by a supra-systolic cuff pressure 50 mm Hg above the subject's baseline systolic BP [17, 31] and signal acquisition was continued during the period of occlusion. Completeness of occlusion was ensured by constantly verifying the absence of pulse wave form signal from the computer each group. For intergroup comparison of parameters unpaired t test or Mann Whitney tests were applied as appropriate. The relationship between two parameters was evaluated using Pearson's correlation coefficient or Spearman's rank correlation coefficient if they were appropriate. The level of statistical significance was set at p<0.05. All statistical analyses were done using GraphPad prism version 5.00 for Windows (GraphPad Software, Inc., USA).
Results
The objectives of the present study were to non-invasively assess the vascular reactivity and endothelial function in patients of endogenous hypercortisolism and study its relationship with serum cortisol levels and markers of oxidative stress. During the period from October 2008 to December 2010, 28 consecutive cases of CS admitted in the endocrine ward were recruited to the study. Out of these 10 had to be excluded (8 due to diabetes, 1 due to CKD with diabetes and 1 due to septicaemia). Eighteen patients of CS and fifteen age and gender matched healthy controls participated in the study. Of the 18 patients, 10 were hypertensives and 8 were normotensives. Thirteen of these patients (72%) had ACTH dependent Cushing's syndrome of which 12 had pituitaty lesion and 1 had an unknown source of ACTH. Patients with ACTH independent CS were 5 (28%), and all of them had adrenal cancer. Baseline characteristics of both the study groups are represented in Table 1 . Patients had a significantly higher BMI, systolic and diastolic BP and morning fasting serum cortisol levels as compared to controls.
Photoplethysmographic pulse wave amplitude and slope responses during reactive hyperemia were studied to assess the vascular reactivity and endothelial function in both the groups. In the control group it was observed that, averaged pulse wave amplitudes during the 2 nd and 3 rd minute post release of occlusion [3.11 (2.28-4.11) volts and 2.45 (1.81-3.75) volts respectively] were significantly higher than the baseline values [2.22 (1.59-3.44) volts; p<0.001 and p<0.05 respectively]. In the patient group there was no significant change in the averaged pulse wave amplitude during any of the observed time periods following release of occlusion, in comparison to the baseline. On intergroup comparison after normalization (Fig. 2) , it was observed that the rise in pulse wave amplitude was significantly lower in the patient group during the 2 nd and Estimation of cortisol levels and oxidative stress markers Blood samples were collected from all the subjects in the morning (8:30 am -9:30 am) on the day of vascular function assessment after an overnight fast. For the diagnosis of endogenous hypercortisolism in patients, blood samples were collected at 8:00 am following LDDST and plasma cortisol was estimated by electrochemiluminescence immunoassay (ECLISA) with a measuring range of 0.018µg/dL to 63.4µg/dL (intra & inter assay coefficient of variance 6%) using Elecsys ® autoanalyzer (Roche, USA). Morning fasting serum cortisol levels were estimated in all the subjects on the day of vascular function assessment by a direct immunoenzymatic colourimetric method (Diametra, Italy) with a measuring range of 1.0 µg/dL to 50.0 µg/dL (Intra-assay and inter-assay coefficient of variances of 7% and 9.32% respectively). Measurement of absorbencies were done using microplate reader Benchmark plus (BIORAD, USA).
To assess the oxidative stress, serum malondialdehyde (MDA) and vitamin C levels were estimated in the morning fasting serum samples of both the study groups. Serum MDA was estimated spectrophotometrically using modified Yagi's method [23, 24] which is reported to accurately estimate serum MDA levels within a range varying from 1nmol/mL to 100nmol/ mL (Intra-assay and inter-assay coefficient of variances of 4% and 11% respectively). Serum Vitamin C levels were measured spectrophotometrically by ascorbate oxidase method [25] with a reported measuring range of 0.1mg/dL to 10mg/dL (Intra-assay and inter-assay coefficient of variances of 2.8% and 5.2% respectively). Chemicals required for both the estimations were purchased from 'Sigma' or 'Qualigens'. Absorbencies were measured at the required wavelengths using a double beam UV-VIS spectrophotometer ELICO SL-210 (ELICO, India).
Statistical analysis
Data are expressed as mean±SD or median with interquartile range (1 st quartile -3 rd quartile) depending on the distribution of data. Each parameter was tested for normality in the distribution of data using standard normality tests (D' Agostino-Pearson omnibus normality test and Shapiro-Wilk test), based on which appropriate parametric or non-parametric tests were applied. To assess the significant trends in each parameter during RH, Repeated measures ANOVA or Friedman test with appropriate post hoc tests were applied within was no significant change in the averaged pulse wave slope during any of the observed time periods following release of occlusion, in comparison to the baseline. On intergroup comparison after normalization (Fig. 3) , it was observed that the rise in pulse wave slope was significantly lower in the patient group during the 2 followed by a recovery to near baseline values by 4 th minute post release of occlusion in the control group where as the values remained significantly higher than the baseline in the patient group for the entire recording period (Table 4 and Fig. 4 ). On intergroup comparison after normalization (Fig. 4) , it was observed that the rise in normalized pulse transit time during the 1 st minute post release of occlusion was significantly lower in the patient group as compared to controls (1.036 ± 0.026 versus 1.056 ± 0.029; p = 0.0425).
To study the state of oxidative stress in patients of CS versus normal healthy subjects we measured the serum levels of malondialdehyde and vitamin C in both study groups. Levels of both these oxidative stress markers percentage changes with reference to baseline means and time to reach the peak magnitude were computed for both these parameters (Tables 2 and 3 ). Maximal percentage changes in both pulse wave amplitude and slope were significantly lower in the patient group and time to reach the peak slope was significantly shorter in the patient group as compared to controls.
To assess the vascular tone responses during reactive hyperemia, beat to beat pulse transit times were obtained from simultaneously acquired ECG and PPG signals. Following the release of occlusion in both control and the patient group it was observed that the averaged pulse transit times were significantly higher than their respective baseline means. This initial rise was age changes in pulse transit time during the 2 nd minute post release of occlusion had a significant negative correlation with morning fasting serum cortisol levels in the patient group (Pearson r = -0.6328, R 2 = 0.4004 and p = 0.0064). None of the other vascular function parameters were correlated to serum cortisol levels in the patient group. No significant correlation was found between any of the vascular function parameters with were neither significantly different between the study groups (Table 5 ) nor they were correlated to any of the vascular function parameters or serum cortisol levels in the patient group.
We also evaluated the relationship between various vascular function parameters and the levels of hypercortisolism in the patient group. On univariate correlation analysis (Fig. 5) it was observed that percent- mal conduit arteries [16, 17, 22] . This rise in digital pulse waveform amplitude during reactive hyperemia has been shown to be dependent on endothelial nitric oxide synthesis [18] . Vascular tone changes in conduit and resistance vessels during reactive hyperemia are mainly due to myogenic vasorelaxation taking place during the period of arterial occlusion as well as due to the vasorelaxation induced by flow mediated release of NO during the phase of RH [22, 32, 33] .
In the present study, on analysing the time course of pulse wave amplitude and slope responses in the healthy subjects, it was observed that both these parameters remained significantly higher than baseline during the second and third minutes of reactive hyperemia indicating the normal flow mediated vasodilatation of the proximal conduit vessels. These findings were in close agreement with the results obtained by Selvaraj et al in normal subjects [22] .
On intergroup comparison after normalization, it was observed that CS patients had a significantly lower pulse wave amplitude and slope during the second and third minutes of reactive hyperemia as compared to controls. Similarly, the maximum percentage changes in pulse wave slope & amplitude during RH from the baseline means were significantly lower in the patient group in comparison to controls. Both these findings clearly indicated a significant impairment of FMD of conduit vessels in CS which is in accordance with the previous reports based on ultrasonographic method [13, 15] . The impaired FMD in CS could be either due to a decreased bioavailability of endothelial NO [15] or a diminished response of vascular smooth muscle to the available NO. The design of this study limits us from localizing the exact site of this impairment specifically to endothelium or vascular smooth muscle.
To the best of our knowledge, this is the first study to assess the vascular tone responses during reactive hyperemia in CS patients. On analysing the time course of changes in pulse transit time, it was observed that, in both the control and the patient groups there was a significant rise in the PTT values above the respective baseline values subsequent to the release of occlusion which was followed by a recovery towards the baseline values in the control group where as in the patient group, PTT values remained significantly higher than the baseline till the end of the recording period. On intergroup comparison it was observed that normalised PTT values for the first minute of reactive hyperemia was significantly lower in the patient group when compared to systolic and diastolic blood pressures, BMI or duration of illness in the patient group.
discussion
The present study was conducted in eighteen patients of CS and fifteen age and gender matched healthy subjects, to non-invasively assess the vascular reactivity and endothelial function. Peripheral pulse waveform changes during reactive hyperemia were studied using digital photoplethysmography in both the study groups for non invasive assessment of vascular functions.
The patient and control groups were matched for age and gender distribution of the subjects. Baseline systolic and diastolic blood pressures, body mass index (BMI) and fasting morning cortisol levels were significantly higher in the patients as compared to controls. These findings clearly portrayed the existence of typical clinical manifestations of endogenous hypercortisolism in our patient group which have already been reported in the literature [1] [2] [3] .
We had excluded patients with coexisting diabetes mellitus as it has already been proven to directly affect the vascular endothelial function by previous studies [26, 27] . This confounding effect of diabetes mellitus has not been taken care of, while selecting the patient population in all of the previous studies which had assessed vascular function in endogenous hypercortisolism [13] [14] [15] . Approximately 50% of the patients who participated in these studies had coexisting diabetes mellitus. Absence of the diabetic state in our patient population makes this study a better model to investigate the role of hypercortisolism in the pathogenesis of vascular dysfunction in CS.
We have used reactive hyperemia as a physiological model to assess the reactivity of blood vessels to a temporary arrest of circulation. Transient arterial occlusion results in vasodilation of the resistance vessels and a decrease in the tone of both the resistance and conduit vessels due to metabolic and myogenic mechanisms [28] [29] [30] . Restoration of perfusion pressure at the release of arterial occlusion is followed by an increase in blood flow to the ischaemic tissues and a flow mediated vasodilatory response in the proximal conduit vessels [31] . These vascular responses are accompanied by simultaneous changes in peripheral pulse waveform characterised by a gradual increase in the pulse waveform amplitude and slope which tend to maximise around the time point of peak dilatation of proxi-of RH, had a strong and significant negative correlation with morning fasting cortisol levels in the patient group. PTT/pulse wave velocity changes during the second minute of reactive hyperemia would possibly represent the flow mediated, nitric oxide dependent vasorelaxation of the conduit vessels which has been reported as a marker of endothelial function [32, 33] . The results of our correlation analysis are in accordance with findings of Akaza et al. [15] who showed a significant negative correlation between percentage changes in brachial artery diameter during flow mediated dilatation and morning cortisol levels in patients of CS. Although morning serum cortisol level is not considered to be a disease marker in CS due to its inherent inter-individual variations independent of the disease status, our findings indicate the probable pathophysiologic role excess cortisol levels can play in the causation of vascular endothelial dysfunction as already been shown by previous studies [9] [10] [11] .
The possible limitations of our study are the lack of insulin sensitivity data in the patient group and our control group not matched for BMI with respect to the patient group.
Multiple mechanisms have been proposed by which cortisol can affect the vascular endothelial function by reducing the bioavailability of endothelium derived NO using different in-vitro experimental models [36, 37] . Diminished bioavailability of nitric oxide resulting from all these mechanisms can very well explain the impaired vascular reactivity, accelerated rate of atherosclerosis and high incidence of vascular morbidity and mortality seen in CS.
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controls. Both these observations when taken together would indicate an impaired myogenic regulation of vascular smooth muscle tone in CS leading to a diminished myogenic relaxation during the period of occlusion and a delay in the recovery of myogenic vasoconstrictor tone following the release of arterial occlusion and restoration of stretch on the vessel walls. This impairment in myogenic regulation of vascular tone could possibly be a pathophysiologic manifestation of the hypertrophic remodelling of blood vessels in patients with CS which has been shown by previous micromyographic studies [12] . The diminished vasorelaxation during the period of occlusion could also be due to endothelial dysfunction as it has been shown by in vitro studies that, deformation of endothelial cells resulting from the collapse of vessel intima during the period of arterial occlusion induces endothelial nitric oxide release and contributes to the maximal vasorelaxation response observed at the time of release of occlusion [30] .
In the light of previous studies, we hypothesized and investigated the presence of oxidative stress as a putative cause of vascular dysfunction in patients of CS. The results of the present study showed that there was no significant difference in the levels of oxidative stress markers between the patient and control group. This was in contrast to the observation made by Prázny et al. [14] as they had showed a significantly higher oxidative stress in patients of CS in comparison to controls. A probable reason for this disparity could be the high prevalence of coexisting diabetes mellitus (52%) in their patient population (while we excluded it), as diabetes mellitus has already been proven to induce a state of oxidative stress by itself [34, 35] .
To investigate the role of excess cortisol levels in the causation of vascular dysfunction in CS, we looked for correlation between pulse waveform parameters and morning cortisol levels in the patient group. On univariate correlation analysis it was observed that, percentage changes in PTT during the second minute
